GDRX vs. PGNY: Which Stock Should Value Investors Buy Now?

Core Viewpoint - Investors in the Medical Services sector may find GoodRx Holdings, Inc. (GDRX) and Progyny (PGNY) as potential stocks to consider, with GDRX appearing more attractive for value investors [1] Valuation Metrics - GoodRx Holdings, Inc. has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while Progyny has a Zacks Rank of 4 (Sell) [3] - GDRX has a forward P/E ratio of 9.59, significantly lower than PGNY's forward P/E of 14.46, suggesting GDRX may be undervalued [5] - The PEG ratio for GDRX is 0.86, compared to PGNY's PEG ratio of 0.94, indicating GDRX's expected earnings growth is more favorable [5] - GDRX's P/B ratio is 2, while PGNY's P/B ratio is 4.73, further supporting GDRX's valuation as more attractive [6] - GDRX's overall Value grade is A, while PGNY's Value grade is C, highlighting GDRX's stronger position in terms of value metrics [6] Earnings Outlook - GDRX is noted for its improving earnings outlook, which enhances its attractiveness in the Zacks Rank model [7]